US Stock MarketDetailed Quotes
NRXS Neuraxis
- 2.400
- 0.0000.00%
Close Dec 20 16:00 ET
16.75MMarket Cap-1.99P/E (TTM)
2.492High2.310Low16.17KVolume2.350Open2.400Pre Close38.37KTurnover0.52%Turnover RatioLossP/E (Static)6.98MShares3.89052wk High-9.34P/B7.52MFloat Cap2.00052wk Low--Dividend TTM3.13MShs Float6.930Historical High--Div YieldTTM7.56%Amplitude1.800Historical Low2.372Avg Price1Lot Size
About Neuraxis Company
NeurAxis, Inc. develops neuromodulation therapies to address chronic and debilitating conditions in children. Its product IB-Stim is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.
Company Profile
SymbolNRXS
Company NameNeuraxis
Listing DateAug 9, 2023
Issue Price6.00
Founded2011
CEOMr. Brian Carrico
MarketAMEX
Employees19
Fiscal Year Ends12-31
Address11611 North Meridian Street,Suite 330
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-812-689-0791
Websitehttp://neuraxis.com
Company Executives
- Name
- Position
- Salary
- Brian Carrico
- President, Chief Executive Officer and Director
- 839.40K
- Dr. Thomas Carrico
- Chief Regulatory Officer, Compliance Officer and Privacy Officer
- 411.10K
- Dr. Adrian Miranda
- Chief Medical Officer, Senior Vice President, Science and Technology
- 323.05K
- Timothy Henrichs
- Chief Financial Officer
- 43.70K
- Christopher Robin Brown
- Independent Director
- --
- Bradley Mitch Watkins
- Independent Director
- 43.70K
- Beth Keyser
- Independent Director
- 43.70K
- Kristin A. Ferge
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data